MALTOFER Drops 30ml - Established Iron Deficiency

MALTOFER Drops 30ml - Established Iron Deficiency Description

MALTOFER Drops 30ml Medicine used in Established Iron Deficiency Ingredients: 1 ml of drops contain 50 mg of iron as iron (III) hydroxide polymaltose complex. Excipients: flavor, methylhydroxybenzoate, propylhydroxybenzoate, sucrose, purified water. Properties and action Maltofer drops is an iron medicine for the treatment of latent iron deficiency and iron deficiency anemia. Iron is an important constituent of hemoglobin, myoglobin and enzymes that contain iron. The treatment of iron deficiency in children up to one year is very important. Iron deficiency in this age can affect brain development. Iron deficiency may be the cause of chronic fatigue, lack of concentration, irritability, nervousness, headache, lack of appetite, increased susceptibility to stress and infections, paleness, cracks in the corners of the mouth (cracks), dry skin, brittle hair and nails, as well as loss of interest in games for children. Maltofer iron droplets in the form of iron III hydroxide polymaltose complex, wherein the single particles are embedded in a carbohydrate polymer (polymaltose). This protection prevents interactions between iron and food and provides the bioavailability of iron. The structure of Maltofer drops is similar to ferritin - a natural depot of iron in the body. Following this similarity, iron is absorbed through natural mechanisms of absorption. Iron III hydroxide polymaltose complex will prooksidativni properties as divalent iron salts. Evidence Treatment of latent iron deficiency and iron deficiency anemia (iron deficiency manifest). Prevention of iron deficiency to meet the recommended daily dietary needs during pregnancy and lactation, children, adolescents, women of childbearing age and adults (including vegetaryantsi and old people). Dosage The dosage and duration of treatment depends on the severity of iron deficiency. Manifest iron deficiency, treatment lasts approximately 3-5 months to reach a normal hemoglobin levels. Then therapy should be continued for several weeks, and in pregnant women to birth at a dose as described for latent iron deficiency, to fill up the iron stores. Latent iron deficiency, treatment lasts 1-2 months. Infants (up to 1 year): Manifest iron deficiency - 10-20 drops per day (25-50 mg iron); Latent iron deficiency - 6-10 drops daily (15-25 mg iron); Prevention - 2-4 drops per day (5-10 mg iron); Children (1-12 years): Manifest iron deficiency - 20-40 drops per day (50-100 mg iron); Latent iron deficiency - 10-20 drops per day (25-50 mg iron); Prevention - 4-6 drops daily (10-15 mg iron); Children (> 12 years), elderly and nursing mothers: Manifest iron deficiency - 40-120 drops per day (100-300 mg iron); Latent iron deficiency - 20-40 drops per day (50-100 mg iron); Prevention - 4-6 drops daily (10-15 mg iron); Pregnant women: Manifest iron deficiency - 80-120 drops per day (200-300 mg iron); Latent iron deficiency - 40 drops per day (100 mg of iron); Prevention - 20-40 drops per day (50-100 mg iron); Prematurity: Manifest iron deficiency - 1-2 drops per day per kg body weight (2,5-5 mg iron). Application The daily dosage may be divided into individual doses or may be administered at one time. Maltofer drops should be administered during or immediately after a meal. Maltofer drops can be mixed with fruit or vegetable juice or milk to the infant. The slight coloring does not affect the taste and efficacy. In case of acute need for iron / low hemoglobin parallel EPO treatment and others. /, Parenteral iron medicinal products to be used for iron supply, so that the iron is more highly available. Contraindications Overloading the body with iron (hemochromatosis, hemosiderosis) or disturbances in utilization of iron (anemia due to lead poisoning, sideroahrestichna anemia, thalassemia) and anemia not caused by iron deficiency (hemolytic anemia). Special warnings and precautions for use Note for diabetics: 0.01 bread units per ml (20 drops). In people with hereditary fructose intolerance, glucose / galactose malabsorption syndrome or sucrase / isomaltase deficiency. In the case of anemia due to infection or malignancy, the substituted iron is stored in the reticuloendothelial system of which is mobilized and distributed only after treatment of the primary disease. Interactions So far, no interactions were observed. When the iron is complex-bound, not observed ionic interactions with the components of the food / phytin, oxalates, tannin and the like. / Or concomitant medication / tetracycline and antacids /. Haemoccult test / specific hemoglobin / detection of occult / hidden / bleeding is not disturbed, so there is no need to interrupt treatment with iron. Pregnancy and lactation Pregnancy Category A: Reproductive studies in animals have shown no risk to the fetus. Controlled studies in pregnant women after the first trimester, do not indicate any adverse effects on the mother and fetus. No evidence of risk during the first trimester and unintended negative impact on the fetus. The application of Maltofer drops does not lead to adverse effects on the infant. During pregnancy and lactation, Maltofer drops should be taken only after consulting a doctor or pharmacist. Adverse reactions Occasionally gastrointestinal irritation as a feeling of fullness, heaviness in the epigastric (upper abdomen), nausea, constipation or diarrhea. Dark colored stool in connection with iron is not clinically significant. Maltofer drops do not cause dark staining of the teeth. Overdose Neither intoxication nor iron overload observed in case of overdose. Note: Specially produced for Bulgarian market by Vifor Pharma France Storage Keep out of reach of children. Store in the original container below 25 C. Formulation and packaging 30ml bottle with an attached drip applicator. Marketing Authorisation Holder and Manufacturer: Vifor Pharma SA, France.